Tenax Therapeutics, Inc.TENXNASDAQ
Loading
Year-over-year debt growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P49
Within normal range
Average
2.07%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | -100.00% |
| Q2 2024 | -32.52% |
| Q1 2024 | -17.51% |
| Q4 2023 | 187.11% |
| Q3 2023 | -49.54% |
| Q2 2023 | -32.72% |
| Q1 2023 | -36.39% |
| Q4 2022 | 281.82% |
| Q3 2022 | -36.06% |
| Q2 2022 | -33.00% |
| Q1 2022 | 69.86% |
| Q4 2021 | -7.95% |
| Q3 2021 | -7.23% |
| Q2 2021 | 23.64% |
| Q1 2021 | -9.72% |
| Q4 2020 | -8.63% |
| Q3 2020 | -7.80% |
| Q2 2020 | 149.55% |
| Q1 2020 | -15.51% |
| Q4 2019 | -13.09% |
| Q3 2019 | -11.37% |
| Q2 2019 | -10.03% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | -100.00% |
| Q1 2016 | -99.95% |